U S Physical Therapy Inc. (USPH) is the issuer in a Schedule 13G reporting that Copeland Capital Management, LLC beneficially owned 940,528 common shares, or 6.3% of the class, as of September 30, 2026. The report lists sole voting power over 612,654 shares and shared voting power over 150,697 shares; it lists shared dispositive power over 763,351 shares and sole dispositive power over zero shares.
U S Physical Therapy Inc. (USPH) director Myra Davis acquired 1,210 shares of restricted stock under the company's Amended and Restated 2003 Stock Incentive Plan on October 1, 2026. Her reported direct holdings after the transaction were 1,210 shares. Restrictions lapse in installments: 303 shares will vest on each of November 20, 2026, and March 6, 2027, and 605 shares will vest on May 20, 2027, subject to her continued service as a director through each applicable vesting date.
U.S. Physical Therapy, Inc. entered into a 45-month forward-starting interest rate swap with Bank of America, National Association, with an initial notional amount of $170.6 million. The swap fixes the variable component of the interest rate on term debt under the company’s credit agreement effective June 30, 2027, when its existing interest rate swap expires.
U.S. Physical Therapy will make monthly payments at a fixed rate of 4.578% per annum and receive variable payments based on the one-month SOFR interest rate for the same notional amount. The swap amortizes in line with the term-loan payment schedule and terminates April 14, 2031.
U.S. Physical Therapy, Inc. (USPH) reported that its Board of Directors approved the appointment of Myra Davis as a director, effective October 1, 2026. Davis, age 61, is Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital and has held senior IT leadership roles there since 2003.
Upon joining the Board, Davis will receive cash and equity compensation determined under the processes described in the company’s April 16, 2026 proxy statement. The company states there are no arrangements under which she was selected and no related-party transactions requiring disclosure. USPH notes it owns and/or manages 799 outpatient physical therapy clinics across 45 states.
U S PHYSICAL THERAPY INC /NV (symbol: USPH) is the issuer of record for a Form 4 filing submitted to the SEC. Etta Nchacha reported acquisition or exercise transactions in this Form 4 filing.
U S PHYSICAL THERAPY INC /NV (USPH) reported that its EVP & Chief Financial Officer, Etta Nchacha, received a grant of 6,831 shares of Common Stock on September 14, 2026. The award is in the form of restricted stock granted under the company's Amended and Restated 2003 Stock Incentive Plan.
The 6,831 restricted shares will vest in service-based installments: 427 shares on each of 15 dates from November 20, 2026 through May 20, 2030, and 426 shares on August 20, 2030, in each case subject to her continued employment through the applicable vesting date. After this grant, she holds 6,831 shares directly. No Rule 10b5-1 trading plan is reported.
U S PHYSICAL THERAPY INC /NV (USPH) director Peter Francis Minan reported small acquisitions of common stock tied to dividend reinvestment and existing equity awards. On September 11, 2026 he purchased 5.27 shares at $79.00 per share, and on June 12, 2026 he acquired 0.87 shares at $66.50 per share through automatic reinvestment of cash dividends in his brokerage account, with the June transaction previously unreported. His holdings include 1,153 restricted shares granted under the company’s Amended and Restated 2003 Stock Incentive Plan, scheduled to vest in tranches on November 20, 2026 and March 6, 2027 if he remains a director, and no Rule 10b5-1 trading plan is reported.
U S PHYSICAL THERAPY INC /NV (USPH) reported an initial statement of beneficial ownership on Form 3 for Etta Nchacha, who serves as EVP & Chief Financial Officer. The filing reports no equity holdings or insider transactions at this time and notes an attached Power of Attorney.
U S PHYSICAL THERAPY INC /NV (USPH) reported that President and COO Eric Joseph Williams surrendered 714 shares of Common Stock on August 20, 2026 at $78.00 per share to the company to satisfy applicable tax withholding obligations upon the vesting of equity awards. After this tax-withholding disposition, he directly holds 39,617 shares, including 24,402 shares of restricted stock granted under the Company's Amended and Restated 2003 Stock Incentive Plan.
The filing details a vesting schedule for these restricted shares running through March 6, 2030, with specific tranches vesting on multiple dates each year. Vesting remains subject to his continued employment with the company through each applicable vesting date.
U S PHYSICAL THERAPY INC /NV (USPH) reported that officer CURTIS JASON TRAVIS, Interim CFO, surrendered 40 shares of common stock on August 20, 2026 to the issuer to satisfy tax withholding obligations upon vesting of equity awards, at a reference price of $78.00 per share. After this tax-withholding disposition, he directly holds 3,853 shares of common stock, including 3,425 shares of restricted stock that will vest in scheduled tranches between November 20, 2026 and March 6, 2030, contingent on continued service.